Sleep aid use during and following breast cancer adjuvant chemotherapy
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Knowledge of sleep aid use is limited despite the high prevalence of insomnia among women before, during, and following breast cancer adjuvant chemotherapy treatments (CTX). This study's purpose was to (1) determine the frequency and characteristics of participants taking sleep aid(s); (2) identify the frequency and percentage of sleep aid use by category (prescription sedative/hypnotics, prescription anti‐depressants, prescription analgesics, prescription anti‐emetics, over‐the‐counter (OTC) analgesics, OTC cold/flu/sinus, OTC sleep, alcohol, and herbal supplements); and (3) compare sleep aid use by category in the experimental and control groups within a randomized‐controlled clinical trial (RCT). Methods: Longitudinal, descriptive, secondary RCT data analysis of women (n=219) receiving out‐patient CTX, and at 30, 60, and 90 days following the last CTX and 1 year following CTX1. Participants recorded daily sleep aid use on a Sleep Diary. Analyses included descriptives, chi‐square, and RM‐ANOVA. Results: Approximately 20% of participants took at least one sleep aid before CTX1; usage decreased over time (12–18%); a second sleep aid was used infrequently. Prescription sedative/hypnotics (46%) and OTC analgesics (24%) were used most frequently. OTC sleep aids were most commonly used as a second aid. Prescription sedative/hypnotics [F(7,211)=4.26, p=0.00] and OTC analgesics [F(7,211)=2.38, p=0.023] use decreased significantly over time. Conclusions: Results reflect the natural course of CTX, recovery, and healing. Comprehensive screening for sleep–wake disturbances and sleep aid use may lead to a better understanding of the risks and benefits of pharmacologic and non‐pharmacologic interventions, and ultimately lead to selection of the safest and most effective treatment. Copyright © 2010 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palesh, O. G., Roscoe, J. A., Mustian, K. M., Roth, T., Savard, J., Ancoli-Israel, S., Heckler, C., Purnell, J. Q., Janelsins, M. C., & Morrow, G. R. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.5011 · Cited by 557 · cited 2×
“Insomnia is prevalent, yet undermanaged, in cancer patients receiving chemotherapy [1,3].”
BackgroundPrevalence, Clinical Characteristics, and Risk Factors for Insomnia in the Context of Breast Cancer
Savard, J., Simard, S., Blanchet, J., Ivers, H., & Morin, C. M. (2001) · SLEEP · doi:10.1093/sleep/24.5.583 · Cited by 414 · cited 3×
“Insomnia is prevalent, yet undermanaged, in cancer patients receiving chemotherapy [1,3].”
BackgroundBehavioral therapy intervention trial to improve sleep quality and cancer-related fatigue
Berger, A. M., Kuhn, B. R., Farr, L. A., Lynch, J. C., Agrawal, S., Chamberlain, J., & Von Essen, S. G. (2009) · Psycho-Oncology · doi:10.1002/pon.1438 · Cited by 161 · cited 4×
“After signing the consent, a stratified randomized sampling procedure was used to control for past sleep quality (good/poor) using the Pittsburgh Sleep Quality Index (PSQI) [16] and the type of CTX prescribed [14].”
BackgroundMethodResultSelf-citation
Cited by
Zachariae, R., Amidi, A., Damholdt, M. F., Clausen, C. D. R., Dahlgaard, J., Lord, H., Thorndike, F. P., & Ritterband, L. M. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx293 · Cited by 212
“While pharmacotherapy remains the most commonly used option for insomnia (8,9), hypnotics such as benzodiazepine receptor agonists are associated with side effects, dependence, and tolerance over time and are usually not curative, requiring maintenance treatment over many years (10).”
BackgroundExercise interventions to improve sleep in cancer patients: a systematic review and meta-analysis
Mercier, J., Savard, J., & Bernard, P. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.11.001 · Cited by 103
Matthews, E. E., Berger, A. M., Schmiege, S. J., Cook, P. F., McCarthy, M. S., Moore, C. M., & Aloia, M. S. (2014) · Oncology Nursing Forum · doi:10.1188/14.onf.41-03ap · Cited by 103
Self-citationWu, I. H. C., Tsai, W., McNeill, L. H., & Lu, Q. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-019-05233-x · Cited by 29
Metadata
- Authors
- Moore, T. A., Berger, A. M., & Dizona, P.
- Venue
- Psycho-Oncology
- Publisher
- Wiley
- Published
- 2011-02-23
- Volume
- 20
- Issue
- 3
- Pages
- 321-325
- ISSN
- 1057-9249 (ISSN-L)
- 1099-1611
- OpenAlex
- W1967387336
- Cited by
- 42
- References
- 3
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sleep aid use during and following breast cancer adjuvant chemotherapy. https://app.cochat.ai/papers/10.1002/pon.1756
- The paper
- Moore, T. A., Berger, A. M., & Dizona, P. (2011). Sleep aid use during and following breast cancer adjuvant chemotherapy. Psycho-Oncology. https://doi.org/10.1002/pon.1756
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.